De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Daan Gene Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Luo Huang

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	2.3yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	2.4yrs

Recente managementupdates

Recent updates

CEO

Luo Huang (44 yo)

2.3yrs

Tenure

CN¥5,967,200

Compensatie

Ms. Luo Huang is Non-Executive Director of Yunkang Group Limited from August 11, 2022. She serves as General Manager at Daan Gene Co., Ltd. She served as Deputy General Manager at Daan Gene Co., Ltd.since...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Luo Huang	GM & Director	2.3yrs	CN¥5.97m	geen gegevens
Bin Zhang	Deputy GM	5.5yrs	CN¥5.34m	geen gegevens
Zhengfu Zhu	Independent Director	2.4yrs	CN¥70.90k	geen gegevens
Li Qiang Huang	Supervisor	no data	geen gegevens	geen gegevens
Dianhan Wei	Vice Chairman Of the Board	3.7yrs	geen gegevens	geen gegevens
Wanyu Zhu	Chairman of the Supervisory Board	3.7yrs	geen gegevens	geen gegevens
Teng Hu	Supervisor	3.7yrs	geen gegevens	geen gegevens
Qian Long	Director	2.4yrs	geen gegevens	geen gegevens
Xiaoping Chen	Supervisor	2.4yrs	geen gegevens	geen gegevens
Yunhai Ji	Independent Director	2.4yrs	geen gegevens	geen gegevens

2.4yrs

Gemiddelde duur

47.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 002030 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.4 jaar), wat duidt op een nieuw bestuur.

Daan Gene Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Daan Gene Co., Ltd., Annual General Meeting, Apr 19, 2024

Less than half of directors are independent

Insufficient new directors

Insufficient new directors

Daan Gene Co., Ltd., Annual General Meeting, Apr 20, 2022

Da an Gene Co., Ltd. of Sun Yat-Sen University Announces Executive Changes

Recent updates

Daan Gene Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Second quarter 2024 earnings released: CN¥0.025 loss per share (vs CN¥0.27 profit in 2Q 2023)

New minor risk - Share price stability

Daan Gene Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Dividend reduced to CN¥0.015

Daan Gene Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 14 June 2024

First quarter 2024 earnings released: CN¥0.26 loss per share (vs CN¥0.026 profit in 1Q 2023)

Full year 2023 earnings released: EPS: CN¥0.075 (vs CN¥3.86 in FY 2022)

Daan Gene Co., Ltd., Annual General Meeting, Apr 19, 2024

Now 21% overvalued

Investor sentiment deteriorates as stock falls 15%

Now 20% overvalued

Daan Gene Co., Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024

Third quarter 2023 earnings released: CN¥0.035 loss per share (vs CN¥0.94 profit in 3Q 2022)

Daan Gene Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023

New major risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥1.36 in 2Q 2022)

Less than half of directors are independent

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 15%

Daan Gene Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 13, 2023

Investor sentiment deteriorates as stock falls 18%

Full year 2022 earnings released: EPS: CN¥3.95 (vs CN¥2.58 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.94 (vs CN¥0.66 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.34 (vs CN¥0.33 in 2Q 2021)

Insufficient new directors

Upcoming dividend of CN¥1.11 per share

Daan Gene Co., Ltd. Proposes Final Cash Dividend on A Shares for the Year 2021, Payable on May 9, 2022

Insufficient new directors

Daan Gene Co., Ltd. Approves Final Dividend for the Year 2021

Daan Gene Co., Ltd., Annual General Meeting, Apr 20, 2022

Daan Gene Co., Ltd. Proposes Final Cash Dividend for 2021

Full year 2021 earnings released: EPS: CN¥2.58 (vs CN¥1.75 in FY 2020)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

Da An Gene Co., Ltd. of Sun Yat-Sen University Announces Final Dividend Implementation Plan (A Shares) for 2020, Payable on 19 May 2021

First quarter 2021 earnings released: EPS CN¥1.29 (vs CN¥0.21 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥2.77 (vs CN¥0.10 in FY 2019)

New 90-day low: CN¥29.03

Da an Gene Co., Ltd. of Sun Yat-Sen University Announces Executive Changes

Da An Gene Co., Ltd. of Sun Yat-Sen University to Report Fiscal Year 2020 Results on Mar 31, 2021

Investor sentiment deteriorated over the past week

New 90-day high: CN¥42.15

New 90-day low: CN¥31.98

First half earnings released

First half earnings released

Da An Gene Co., Ltd. of Sun Yat-Sen University to Report First Half, 2020 Results on Aug 29, 2020

New 90-day high - CN¥40.83

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd